Daily Research News Online

The global MR industry's daily paper since 2000

Discuss Adds Privacy Features to 'Made for Pharma'

November 3 2022

In the US, video feedback platform Discuss has added a number of privacy and security capabilities to its 'Made for Pharma' solution, enabling experiences to be shared while mitigating the risks associated with so doing.

Simon GlassSeattle-based Discuss offers an enterprise-level consumer conversation platform that combines video with qualitative research workflow. Its new capabilities include the ability to anonymize recordings and names with 'blurring', to protect recruiters and respondents' personally identifiable information. Further options ensure observers can be restricted from hearing native audio (via voice modulation).

CEO Simon Glass (pictured) comments: 'We know how important privacy and security is, especially for our customers in highly regulated industries. With this new suite of capabilities, our goal is to help them protect the privacy of respondents and ensure their data is safe and secure. By putting the control in our customers' hands, they can select the features that best suit their specific needs'.

Web site: www.discuss.io .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

Select a region below...
View all recent news
for UK
UK
USA
View all recent news
for USA
View all recent news
for Asia
Asia
Australia
View all recent news
for Australia

REGISTER FOR NEWS EMAILS

To receive (free) news headlines by email, please register online